Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-07-19 229848
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-07-19 229851
CERETEC GE HEALTHCARE CANADA INC Anticipated shortage 0.5MG Updated Report 2024-07-19 232987
JAMP-FOLIC ACID JAMP PHARMA CORPORATION Actual shortage 5MG Updated Report 2024-07-19 158129
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Anticipated shortage 25MG New Report 2024-07-19 233457
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Anticipated shortage 25MG Updated Report 2024-07-19 223395
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION ACCORD HEALTHCARE INC Anticipated shortage 25MG Updated Report 2024-07-19 225238
CISPLATIN INJECTION, BP ACCORD HEALTHCARE INC Actual shortage 1MG Updated Report 2024-07-19 225228
PACLITAXEL INJECTION USP ACCORD HEALTHCARE INC Actual shortage 6MG Updated Report 2024-07-19 225231
ATIVAN PFIZER CANADA ULC Anticipated shortage 2MG Updated Report 2024-07-19 232288
MAGNESIUM SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 500MG Updated Report 2024-07-19 233435
CASPOFUNGIN FOR INJECTION FRESENIUS KABI CANADA LTD Anticipated shortage 50MG Updated Report 2024-07-19 233432
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 2MG Updated Report 2024-07-19 230033
APO-METHYLPHENIDATE APOTEX INC Resolved 10MG Updated Report 2024-07-19 231036
DIAMICRON MR SERVIER CANADA INC Actual shortage 60MG Updated Report 2024-07-19 230501
APO-DICLO APOTEX INC Resolved 50MG Updated Report 2024-07-19 232306
APO-NAPROXEN APOTEX INC Resolved 500MG Updated Report 2024-07-19 230489
APO-OMEPRAZOLE APOTEX INC Resolved 20MG Updated Report 2024-07-19 229430
APO-BISOPROLOL APOTEX INC Resolved 5MG Updated Report 2024-07-19 225023
APO-TICAGRELOR APOTEX INC Resolved 60MG Updated Report 2024-07-19 229398

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 150MG New Report 2024-07-19 233446
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 100MG New Report 2024-07-19 233443
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 25MG New Report 2024-07-19 233440
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC To be discontinued 500MG Updated Report 2024-07-19 233046
NORMOSOL-R ICU MEDICAL CANADA INC To be discontinued 0.502G 0.222G 0.526G 0.014G 0.037G Updated Report 2024-07-19 205624